Accessibility Menu
 

Affimed

(OTC) AFMDQ

Current Price$0.00
Market Cap$1,500
Since IPO (2014)-100%
5 Year-100%
1 Year-100%
1 Month+9,900%

Affimed Financials at a Glance

Market Cap

$1,500

Revenue (TTM)

$877.00K

Net Income (TTM)

$69.97M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

1320.79 (High)

Price

$0.00

Volume

729

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $1.13

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Affimed

Industry

Biotechnology

Employees

78

CEO

Shawn M. Leland, PharmD

Headquarters

Mannheim, 68165, DE

AFMDQ Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-13%

Net Income Margin

-13%

Return on Equity

0%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.50K

Shares Outstanding

15.23M

Volume

729

Short Interest

0.00%

Avg. Volume

2.94K

Financials (TTM)

Gross Profit

$8.28M

Operating Income

$106.66M

EBITDA

$102.38M

Operating Cash Flow

$110.27M

Capital Expenditure

$3.73M

Free Cash Flow

$114.00M

Cash & ST Invst.

$72.90M

Total Debt

$19.35M

Affimed Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$155.00K

-92.1%

Gross Profit

$155.00K

-92.1%

Gross Margin

100.00%

N/A

Market Cap

$1.50K

N/A

Market Cap/Employee

$19.74

N/A

Employees

76

N/A

Net Income

$15.14M

+37.8%

EBITDA

$14.45M

+37.7%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Net Cash

$12.05M

-84.2%

Accounts Receivable

$4.54M

+85.7%

Inventory

$0.00

-100.0%

Long Term Debt

$5.99M

-58.8%

Short Term Debt

$6.90M

+5.6%

Return on Assets

-1.09%

N/A

Return on Invested Capital

-1.50%

N/A

Free Cash Flow

$11.14M

+48.1%

Operating Cash Flow

$11.13M

+39.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ONCROncorus, Inc.
$0.13-3.08%
IDRAIdera Pharmaceuticals, Inc.
$0.42-23.04%
PHASPhaseBio Pharmaceuticals, Inc.
$0.07+0.00%
ARAVAravive, Inc.
$0.04-13.39%

Trending Stocks

Symbol / CompanyPricePrice Chg
PBMPsyence Biomedical
$5.87+1.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$56.43+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$58.61-0.01%
SMRNuScale Power
$11.41-0.03%

Questions About AFMDQ

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.